Search
Newly Listed Hong Kong Stock Insilico Medicine Soars Over 45%, with Public Offering Subscription Reaching a Staggering 1427.37 Times
2025-12-30 /
Read about 0 minute
Author：小编
The newly listed Hong Kong stock, Insilico Medicine (03696.HK), experienced a remarkable surge of over 45%. During the public offering stage, it attracted an astonishing 1427.37 times subscription, while the international placing stage saw a subscription rate of 26.27 times. Established in 2014 and with its headquarters situated in Hong Kong, China, Insilico Medicine stands as a pioneering enterprise in the field of AI-powered drug discovery and development. The company set the share price at HK$24.05 each. With a global offering of 94.6905 million shares, it is projected to raise approximately HK$2.277 billion.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
